A Phase 1 Study to Investigate the Mechanism of Action of Ipragliflozin
This study has been completed.
Astellas Pharma Europe B.V.
First Posted: June 5, 2012
Last Update Posted: August 22, 2017
Information provided by (Responsible Party):
Astellas Pharma Inc ( Astellas Pharma Europe B.V. )
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||February 3, 2012|
|Primary Completion Date:||February 3, 2012 (Final data collection date for primary outcome measure)|